These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
522 related articles for article (PubMed ID: 18313248)
1. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience. Mylona S; Kokkinaki A; Pomoni M; Galani P; Ntai S; Thanos L Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248 [TBL] [Abstract][Full Text] [Related]
2. Radiofrequency ablation of renal tumors in the solitary kidney. Krambeck AE; Farrell MA; Callstrom MR; Atwell TD; Charboneau JW; Chow GK; Dimarco DS; Patterson DE Can J Urol; 2008 Aug; 15(4):4163-8; discussion 4168. PubMed ID: 18706143 [TBL] [Abstract][Full Text] [Related]
3. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment? Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792 [TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation of small renal cell carcinomas using multitined expandable electrodes: preliminary experience. Clark TW; Malkowicz B; Stavropoulos SW; Sanchez R; Soulen MC; Itkin M; Patel A; Mondschein JI; Wein AJ J Vasc Interv Radiol; 2006 Mar; 17(3):513-9. PubMed ID: 16567676 [TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes. Raman JD; Thomas J; Lucas SM; Bensalah K; Lotan Y; Trimmer C; Cadeddu JA Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445 [TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation in combination with embolization in metachronous recurrent renal cancer in solitary kidney after contralateral tumor nephrectomy. Gebauer B; Werk M; Lopez-Hänninen E; Felix R; Althaus P Cardiovasc Intervent Radiol; 2007; 30(4):644-9. PubMed ID: 17436034 [TBL] [Abstract][Full Text] [Related]
8. Is radiofrequency ablation safe for solitary kidneys? Jacobsohn KM; Ahrar K; Wood CG; Matin SF Urology; 2007 May; 69(5):819-23; discussion 823. PubMed ID: 17482911 [TBL] [Abstract][Full Text] [Related]
9. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644 [TBL] [Abstract][Full Text] [Related]
10. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. Levinson AW; Su LM; Agarwal D; Sroka M; Jarrett TW; Kavoussi LR; Solomon SB J Urol; 2008 Aug; 180(2):499-504; discussion 504. PubMed ID: 18550123 [TBL] [Abstract][Full Text] [Related]
11. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study. Nakasone Y; Kawanaka K; Ikeda O; Tamura Y; Yamashita Y Acta Radiol; 2012 May; 53(4):410-4. PubMed ID: 22393159 [TBL] [Abstract][Full Text] [Related]
12. Percutaneous radiofrequency ablation of renal tumours: case series of 11 tumours and review of published work. Watkins TW; Parkinson R Australas Radiol; 2007 Oct; 51(5):412-9. PubMed ID: 17803791 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients. Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging. Miki K; Shimomura T; Yamada H; Kishimoto K; Ohishi Y; Harada J; Egawa S Int J Urol; 2006 Jul; 13(7):880-4. PubMed ID: 16882047 [TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation of renal tumors with an expandable multitined electrode: results, complications, and pilot evaluation of cooled pyeloperfusion for collecting system protection. Rouvière O; Badet L; Murat FJ; Maréchal JM; Colombel M; Martin X; Lyonnet D; Gelet A Cardiovasc Intervent Radiol; 2008; 31(3):595-603. PubMed ID: 18247086 [TBL] [Abstract][Full Text] [Related]
16. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up. Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597 [TBL] [Abstract][Full Text] [Related]